You have been chosen to receive this valuable information.

Learn 100+ Physician Perspectives on Biosimilars

Biosimilars are expected to account for 30% of the accessible market. Before their projected growth, they must overcome three fundamental challenges: patent litigation, interchangeability, and stakeholder support.

AmerisourceBergen commissioned a study of 100+ physicians who gave their perspectives on biosimilar products and the challenges they anticipate with utilization.

In this research you’ll learn:

Physician understanding of and confidence in biosimilars
Desired level of cost reduction
Willingness to switch to biosimilars
And more

Access The Results

Biosimilars: Market Insights and Growth Factors

How to ensure the promise of biosimilars becomes a reality.

Find Out Now

Biosimilars: Launch Insights From the Field

Three ways to differentiate your product for improved market share.

See the Insights

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, a MMH Group publication. You are on the mailing list as %%emailaddress%%.